Veterinary Medicines

Albex Gold 200 mg/ml oral suspension for cattle

Authorised
  • Albendazole
Download as PDF

Product identification

Medicine name:
Albex Gold 200 mg/ml oral suspension for cattle
Albex Gold 200 mg/ml, πόσιμο εναιώρημα για βοοειδή
Active substance:
  • Albendazole
Target species:
  • Cattle
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Albendazole
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        7
        day
      • Milk
        84
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Package description:
  • 1L: Container and Closure: White HDPE flexi containers with a Polypropylene cap and an aluminium foil seal.
  • 2.5L: Container and Closure: White HDPE flexi containers with a Polypropylene cap and an aluminium foil seal.
  • 3L: Container and Closure: White HDPE flexi containers with a Polypropylene cap and an aluminium foil seal.
  • 5L: Container and Closure: White HDPE flexi containers with a Polypropylene cap and an aluminium foil seal.
  • 10 L: Container and Closure: High Density Polyethylene (HDPE) white container with a HDPE cap and an aluminium foil seal.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • CY00887V
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0637/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • France
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Poland

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 27/02/2024
Download